Spex Capital (investor - Venture Capital)
See something wrong or missing? Let us know
Offices:London
Spex Capital is a British health-tech VC firm led by Claudio D’Angelo.
- in 2023, Spex Capital announced targeting €100 million for its debut fund to be deployed in early-stage health-tech ventures, from seed up to series A, offering tickets up to €5 million.
Average round investment:1.36M USD
Average number per year:2.0
Distribution:
2020 (3)2018 (1)
Mostly invests in:
United Kingdom (3)
Software Services (4)
United Kingdom (3)
Software Services (4)
See the entire list
Showing 3 of 4 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Spex Capital mostly invests with:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Spex Capital
| Name | Criteria | |
|---|---|---|
![]() |
Rob Wilmot
96%
|
|
![]() |
Alan Morgan
96%
|
|
![]() |
Alma Angels
96%
|
|
![]() |
Chris Bruce
96%
|
|
![]() |
Craig Fenton
96%
|
|
![]() |
Deepbridge Capital
96%
|
|
![]() |
Felipe Navio
96%
|
|
![]() |
James Meekings
96%
|
|
![]() |
Michael Whitfield
96%
|
|
![]() |
Nesta Impact Investments
96%
|
|
knokcare
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy